当前位置:科学网首页 > 小柯机器人 >详情
辅助性T细胞17分化过程中细胞因子诱导Rorc转录的调控机制
作者:小柯机器人 发布时间:2020/8/25 13:43:32

清华大学董晨等研究人员合作发现,保守的非编码序列CNS6和CNS9在辅助性T细胞17分化过程中控制细胞因子诱导的Rorc转录。该项研究成果于2020年8月21日在线发表在《免疫》杂志上。

据研究人员介绍,RORγt是辅助T细胞17(Th17)细胞的谱系特异性转录因子,其在Th17细胞中的上调受到白介素6(IL-6)和TGF-β的严格调节,但分子机理尚不清楚。
 
研究人员在Rorc基因上鉴定了保守的非编码序列(CNS)6和9,这对于在Th17细胞分化过程中表达至关重要,但对于先天淋巴细胞和γδT细胞中RORγt表达则不是必需的。从机理上讲,IL-6信号转导子和转录激活因子3(STAT3)轴似乎在控制RORγt表达和Rorc基因座的表观遗传激活方面很大程度上依赖于CNS9,而仅部分依赖于CNS6。单独的TGF-β足以通过SMAD蛋白与CNS6的结合,以CNS6依赖性的方式诱导RORγt表达,但不足以诱导CNS9依赖性的表达。
 
这项研究揭示了IL-6和TGF-β下游通过不同的顺式调控元件调控RORγt表达和Th17细胞表达的重要协同机制。
 
附:英文原文

Title: The Conserved Non-coding Sequences CNS6 and CNS9 Control Cytokine-Induced Rorc Transcription during T Helper 17 Cell Differentiation

Author: Dehui Chang, Qi Xing, Yang Su, Xiaohong Zhao, Wei Xu, Xiaohu Wang, Chen Dong

Issue&Volume: 2020-08-21

Abstract: RORγt is the lineage-specific transcription factor for T helper 17 (Th17) cells whoseupregulation in developing Th17 cells is critically regulated by interleukin-6 (IL-6)and TGF-β, the molecular mechanisms of which remain largely unknown. Here we identifiedconserved non-coding sequences (CNSs) 6 and 9 at the Rorc gene, essential for its expression during Th17 cell differentiation but not requiredfor RORγt expression in innate lymphocytes and γδ T cells. Mechanistically, the IL-6-signaltransducer and activator of transcription 3 (STAT3) axis appeared to be largely dependenton CNS9 and only partially on CNS6 in controlling RORγt expression and epigeneticactivation of the Rorc locus. TGF-β alone was sufficient to induce RORγt expression in a CNS6- but not CNS9-dependentmanner through CNS6 binding by SMAD proteins. Our study reveals an important synergisticmechanism downstream of IL-6 and TGF-β in regulation of RORγt expression and Th17cell commitment via distinct cis-regulatory elements.

DOI: 10.1016/j.immuni.2020.07.012

Source: https://www.cell.com/immunity/fulltext/S1074-7613(20)30319-8

期刊信息

Immunity:《免疫》,创刊于1994年。隶属于细胞出版社,最新if:21.522
官方网址:https://www.cell.com/immunity/home
投稿链接:https://www.editorialmanager.com/immunity/default.aspx